• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

获得性血栓性血小板减少性紫癜手术复发风险的管理：一项系统评价

Managing surgical relapse risk in acquired thrombotic thrombocytopenic purpura: a systematic review.

作者信息

Pinheiro Maux Lessa Morgana, Soares Ferreira Junior Alexandre, Graton Margaret, Simon Erin, Ledbetter Leila, Onwuemene Oluwatoyosi A

机构信息

Department of Medicine, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

General and Applied Biology Program, Institute of Biosciences (IBB), Sao Paulo State University (UNESP), Botucatu, Brazil.

出版信息

Res Pract Thromb Haemost. 2024 Jun 19;8(5):102478. doi: 10.1016/j.rpth.2024.102478. eCollection 2024 Jul.

DOI:10.1016/j.rpth.2024.102478
PMID:39114263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11305326/
Abstract

•Thrombotic thrombocytopenic purpura (TTP) may relapse after surgery.•In a systematic review, we assessed preoperative TTP prophylaxis.•Pre-emptive ADAMTS-13 activity measurement prior to surgery may improve relapse risk.•Preoperative TTP prophylaxis may lower surgical relapse risk.

摘要

•血栓性血小板减少性紫癜（TTP）术后可能复发。

•在一项系统评价中，我们评估了术前TTP的预防措施。

•术前进行ADAMTS-13活性的预防性检测可能会降低复发风险。

•术前TTP预防措施可能会降低手术复发风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26fd/11305326/86bbfd78ebd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26fd/11305326/dfcc0c885a13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26fd/11305326/86bbfd78ebd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26fd/11305326/dfcc0c885a13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26fd/11305326/86bbfd78ebd6/gr2.jpg

相似文献

1
Managing surgical relapse risk in acquired thrombotic thrombocytopenic purpura: a systematic review.获得性血栓性血小板减少性紫癜手术复发风险的管理：一项系统评价
Res Pract Thromb Haemost. 2024 Jun 19;8(5):102478. doi: 10.1016/j.rpth.2024.102478. eCollection 2024 Jul.
2
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.获得性血栓性血小板减少性紫癜患者择期手术预防复发：病例系列研究。
J Thromb Haemost. 2019 Mar;17(3):492-498. doi: 10.1111/jth.14381. Epub 2019 Feb 25.
3
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura.免疫芯片分析确定了人类白细胞抗原区域中获得性血栓性血小板减少性紫癜的新易感位点。
J Thromb Haemost. 2016 Dec;14(12):2356-2367. doi: 10.1111/jth.13548. Epub 2016 Dec 3.
4
Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.肥胖型 ADAMTS-13 缺乏症小鼠中巨噬细胞耗竭对血栓性血小板减少性紫癜风险的血小板保护作用。
J Thromb Haemost. 2018 Jan;16(1):150-163. doi: 10.1111/jth.13901. Epub 2017 Nov 28.
5
Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.一项针对血小板减少孕妇的回顾性研究中产科血栓性血小板减少性紫癜的发病率。一种诊断困难但可治疗的疾病。
BMC Pregnancy Childbirth. 2015 Jun 17;15:137. doi: 10.1186/s12884-015-0557-5.
6
De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review.手术后和非手术后新发免疫介导性血栓性血小板减少性紫癜：系统评价。
Blood Rev. 2024 Jul;66:101197. doi: 10.1016/j.blre.2024.101197. Epub 2024 Apr 9.
7
Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.新型重组 ADAMTS-13 药物（BAX930）治疗血栓性血小板减少性紫癜的临床前评估。
J Thromb Haemost. 2016 Jul;14(7):1410-9. doi: 10.1111/jth.13341. Epub 2016 Jul 2.
8
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜
J Thromb Haemost. 2005 Aug;3(8):1663-75. doi: 10.1111/j.1538-7836.2005.01425.x.
9
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.ADAMTS13特异性循环免疫复合物作为获得性血栓性血小板减少性紫癜患者复发的潜在预测指标。
Eur J Intern Med. 2017 Apr;39:79-83. doi: 10.1016/j.ejim.2016.11.003. Epub 2016 Nov 22.
10
Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.血浆输注在先天性血栓性血小板减少性紫癜中的药代动力学。
J Thromb Haemost. 2019 Jan;17(1):88-98. doi: 10.1111/jth.14345. Epub 2018 Dec 31.

本文引用的文献

1
De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review.手术后和非手术后新发免疫介导性血栓性血小板减少性紫癜：系统评价。
Blood Rev. 2024 Jul;66:101197. doi: 10.1016/j.blre.2024.101197. Epub 2024 Apr 9.
2
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.免疫介导性血栓性血小板减少性紫癜的长期复发风险及抗CD20治疗的作用
Blood. 2023 Jan 19;141(3):285-294. doi: 10.1182/blood.2022017023.
3
Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline.
心脏手术后血栓性血小板减少性紫癜：术前基线时存在抗ADAMTS13自身抗体。
Platelets. 2022 Apr 3;33(3):479-483. doi: 10.1080/09537104.2021.1912314. Epub 2021 Apr 14.
4
Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery.血管外科学中 ADAMTS-13、血管性血友病因子和白细胞介素-6 的术前、术中及术后动力学的前瞻性评估。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620930273. doi: 10.1177/1076029620930273.
5
Postsurgical thrombotic microangiopathy: Case series and review of the literature.术后血栓性微血管病：病例系列及文献复习。
Eur J Haematol. 2019 Oct;103(4):307-318. doi: 10.1111/ejh.13284. Epub 2019 Jul 23.
6
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.获得性血栓性血小板减少性紫癜患者择期手术预防复发：病例系列研究。
J Thromb Haemost. 2019 Mar;17(3):492-498. doi: 10.1111/jth.14381. Epub 2019 Feb 25.
7
Successful liver transplantation in a child with acute-on-chronic liver failure and acquired thrombotic thrombocytopenic purpura.一名患有慢加急性肝衰竭和获得性血栓性血小板减少性紫癜的儿童成功进行了肝移植。
Liver Transpl. 2015 May;21(5):704-6. doi: 10.1002/lt.24096. Epub 2015 Apr 1.
8
Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.关节置换术后患者血管性血友病因子和ADAMTS-13的变化。
Mol Med Rep. 2015 Apr;11(4):3015-20. doi: 10.3892/mmr.2014.3041. Epub 2014 Dec 3.
9
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.主动脉瓣狭窄患者行瓣膜置换术或球囊瓣膜成形术前后 von Willebrand 因子裂解蛋白酶（ADAMTS-13）的变化。
Thromb Haemost. 2012 Jul;108(1):86-93. doi: 10.1160/TH11-12-0803. Epub 2012 May 25.
10
Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
Semin Thromb Hemost. 2005 Dec;31(6):700-8. doi: 10.1055/s-2005-925476.